about
Findings from bipolar disorder genome-wide association studies replicate in a Finnish bipolar family-cohortA high-density association screen of 155 ion transport genes for involvement with common migraineGenetic predisposition to acute kidney injury--a systematic reviewA novel missense ATP1A2 mutation in a Finnish family with familial hemiplegic migraine type 2Kinetic alterations due to a missense mutation in the Na,K-ATPase alpha2 subunit cause familial hemiplegic migraine type 2Genome-wide association analysis identifies susceptibility loci for migraine without aura.Genome-wide meta-analysis identifies new susceptibility loci for migraine.Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraineSystematic re-evaluation of genes from candidate gene association studies in migraine using a large genome-wide association data set.A visual migraine aura locus maps to 9q21-q22Novel susceptibility locus at 22q11 for diabetic nephropathy in type 1 diabetes.Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1.Trait components provide tools to dissect the genetic susceptibility of migraine.CRY2 genetic variants associate with dysthymia.The molecular genetics of migraine.Ischemic stroke is associated with the ABO locus: the EuroCLOT studyConsistently replicating locus linked to migraine on 10q22-q23Migraine: a complex genetic disorder.Effect of catechol-o-methyltransferase-gene (COMT) variants on experimental and acute postoperative pain in 1,000 women undergoing surgery for breast cancerElevated MBL concentrations are not an indication of association between the MBL2 gene and type 1 diabetes or diabetic nephropathy.A susceptibility locus for migraine with aura, on chromosome 4q24.Genetic association study of endothelin-1 and its receptors EDNRA and EDNRB in migraine with aura.High risk population isolate reveals low frequency variants predisposing to intracranial aneurysms.Massive withdrawal symptoms and affective vulnerability are associated with variants of the CHRNA4 gene in a subgroup of smokersA novel splice mutation in PLS3 causes X-linked early onset low-turnover osteoporosis.Genetic variants in SERPINA4 and SERPINA5, but not BCL2 and SIK3 are associated with acute kidney injury in critically ill patients with septic shock.Novel splice site CACNA1A mutation causing episodic ataxia type 2.Acetazolamide improves neurotological abnormalities in a family with episodic ataxia type 2 (EA-2).Decreased cerebellar total creatine in episodic ataxia type 2: a 1H MRS study.Association of the SLC22A1, SLC22A2, and SLC22A3 genes encoding organic cation transporters with diabetic nephropathy and hypertension.Subclinical vestibulocerebellar dysfunction in migraine with and without aura.How much oxycodone is needed for adequate analgesia after breast cancer surgery: effect of the OPRM1 118A>G polymorphism.Pain in 1,000 women treated for breast cancer: a prospective study of pain sensitivity and postoperative pain.PRKCDBP (CAVIN3) and CRY2 associate with major depressive disorder.CRY1 and CRY2 genetic variants in seasonality: A longitudinal and cross-sectional study.Analgesic Plasma Concentrations of Oxycodone After Surgery for Breast Cancer-Which Factors Matter?CRY1, CRY2 and PRKCDBP genetic variants in metabolic syndrome.Effect of endocannabinoid degradation on pain: role of FAAH polymorphisms in experimental and postoperative pain in women treated for breast cancer.Genetic variation in P2RX7 and pain tolerance.Migraine without aura: genome-wide association analysis identifies several novel susceptibility.
P50
Q24648372-642721E1-3383-4127-8175-5FC874C1A45DQ24653482-1D0749AF-69F4-4BB1-8648-DE48BE310C94Q26775550-151486A8-3BEF-4AC8-80AB-43C1D1B707A3Q28260868-D0C66B8F-61CD-4EEA-88E4-C872CAF7A900Q28276923-975FFD43-FBB4-478E-9562-62421B21B14EQ29416996-5AC6EFB0-38F4-4366-BA43-C9438D071221Q29417021-06A12EFC-0432-4134-A346-E0D83E39C64CQ30840255-79187792-5FC4-424B-9C9D-2C20FA5EDA70Q30886614-0B1873A8-6BEF-4588-8AE7-6705A7AD5F95Q33834237-7F11A01F-459E-4A08-8691-5A8FBF9465AEQ34016561-1730037E-FB3A-4DD6-A6C8-CFB8605E5E0EQ34023677-8AF770E7-3FB4-41FE-A7BA-7F721909E93AQ34658426-7B5A1AA6-837E-4115-86A9-AF176E7E2E0CQ34949582-649E40AD-FC9B-40A1-8B73-F547874B6C74Q35932365-244601BD-2F19-4B4A-8448-A3A244B78639Q36637803-15BF35DA-3CD3-4E29-B5FB-4E0C8F73A486Q36718993-90C6F79B-2951-4E5E-8654-8F5788A96224Q36825299-7C3FFDBC-7FD7-43BD-B349-3A8920CA283BQ36906731-D57723CA-C10A-4C12-BA46-71C3DC5A2AA0Q37236235-8EF64956-CB31-4070-8D4A-84A5EB5389E4Q37361279-189ADCBA-F21E-42C6-8C79-CFAD52FA0D81Q37382035-2074851E-FCBC-4FB0-808F-19C74702DFCAQ37533975-F41B5DA6-E491-4D00-9250-A87E5924359CQ37534290-834699DC-0F82-42C1-8544-C76970DA8036Q39131312-C72889F6-5154-478B-996A-27ADAD77B6B2Q42088715-4252070B-E286-4E9E-8022-F9B6F9908294Q44609246-78026E68-68AB-4FEF-AFFF-182E6393D3B4Q44780897-33732E29-C230-48F6-8ADD-11D46E255641Q45256313-30F4FEB1-8654-4A03-97F2-62F7316E2A5DQ46198585-97C33757-3EE0-42EE-859A-E45A6023D2AFQ47298862-2C6DEB7E-85D1-4936-A46B-E56CA9FA33B5Q47810985-F17CFF02-7AE0-41E0-A2B7-9F4E1C84DDDAQ47936995-A9A404F5-16A3-4193-BEDB-FF88FE011EC1Q48039577-19298EAD-482F-435E-B874-CE99D49A2844Q48053141-EE1296C7-6A07-4809-BAB2-B90A0936B1F9Q50568090-7661DD7E-CCC0-4DA1-A5C0-BDCD127C52CAQ50613185-90D5C304-571E-4315-BC03-F078FE5306ACQ51471140-E4F0B8CA-B714-4904-9EDF-BE09290A7CB7Q51767986-8F2B02DF-0778-427A-96CB-71633B4EE4C8Q55098383-3287C8D2-D09D-4DFA-B2AB-E445DD5A360F
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Mari A Kaunisto
@nl
Mari A Kaunisto
@sl
Mari Anneli Kaunisto
@en
Mari Anneli Kaunisto
@es
type
label
Mari A Kaunisto
@nl
Mari A Kaunisto
@sl
Mari Anneli Kaunisto
@en
Mari Anneli Kaunisto
@es
altLabel
Kaunisto MA
@en
Mari A Kaunisto
@en
prefLabel
Mari A Kaunisto
@nl
Mari A Kaunisto
@sl
Mari Anneli Kaunisto
@en
Mari Anneli Kaunisto
@es
P106
P21
P31
P496
0000-0002-6946-9195